Data compiled by Redley Lamar · ChainSifter Intelligence
9Suppliers
4Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Theriva Biologics, Inc. (TOVX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
25Total relationships
4Distinct source URLs
14High confidence
0.836Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in accordance with the provisions of the approved labeling. Modifications or enhancem…
Reciprocal relationship from CADL graph: Reciprocal relationship from TOVX graph: prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in …
Reciprocal relationship from CGON graph: Reciprocal relationship from TOVX graph: Reciprocal relationship from CGON graph: Reciprocal relationship from TOVX graph: Reciprocal relationship from CGON g…
prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in accordance with the provisions of the approved labeling. Modifications or enhancem…
Reciprocal relationship from CLDWW graph: Reciprocal relationship from TOVX graph: prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in…
prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in accordance with the provisions of the approved labeling. Modifications or enhancem…
Reciprocal relationship from GNLX graph: Reciprocal relationship from TOVX graph: Reciprocal relationship from GNLX graph: Reciprocal relationship from TOVX graph: Reciprocal relationship from GNLX g…
prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in accordance with the provisions of the approved labeling. Modifications or enhancem…
Reciprocal relationship from MCRB graph: Reciprocal relationship from TOVX graph: Reciprocal relationship from MCRB graph: Reciprocal relationship from TOVX graph: prescribe legally available drugs f…
Theriva Biologics, Inc. Customers
Ticker
Name
Confidence
Evidence
RASAYANA
RASAYANA
92%
Under the terms of the Rasayana License Agreement, the Company received an upfront payment of Three Hundred Thousand Dollars ($ 300,000 ) from Rasayana on the effective date of the Rasayana License A…
RASAYANA-THERAPEUTICS-INC
RASAYANA-THERAPEUTICS-INC
92%
Under the terms of the Agreement, the Company received an upfront payment of Three Hundred Thousand Dollars ($300,000) from Rasayana on the Effective Date.
Reciprocal relationship from GNLX graph: ials between batches from a single supplier or between suppliers; ● the possible breach by our third-party suppliers and service providers of our agreements w…
B-RILEY-SECURITIES-INC
B-RILEY-SECURITIES-INC
62%
exercise and other transactions described in the Inducement Agreement. Pursuant to the terms of an engagement letter, dated October 16, 2025 , by and between the Company and AGP, the Company agreed t…
Theriva Biologics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
TOVX-DEBT-13070
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-06-30.
TOVX-DEBT-13069
Warrants outstanding: 13672173
90%
xbrl warrant detail from xbrl 2025-12-31.
TOVX-DEBT
Debt stack $1.7M
90%
Market cache reports total debt of $1.7M.
Theriva Biologics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Theriva Biologics, Inc..
Theriva Biologics, Inc. Ownership
Holder
Name
Confidence
Evidence
TOVX-OWNER-VANGUARD-GROUP-INC
Vanguard Group Inc
95%
13F/ownership overlay lists Vanguard Group Inc; shares held 255,727; ownership 0.56%; value $51,733; as of 2025-12-31.
TOVX-OWNER-MORGAN-STANLEY
Morgan Stanley
95%
13F/ownership overlay lists Morgan Stanley; shares held 200,000; ownership 0.44%; value $40,459; as of 2025-12-31.
TOVX-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC
Geode Capital Management, LLC
95%
13F/ownership overlay lists Geode Capital Management, LLC; shares held 212,087; ownership 0.46%; value $42,905; as of 2025-12-31.
TOVX-OWNER-TWO-SIGMA-SECURITIES-LLC
Two Sigma Securities, LLC
95%
13F/ownership overlay lists Two Sigma Securities, LLC; shares held 42,893; ownership 0.09%; value $8,677; as of 2025-12-31.
TOVX-OWNER-XTX-TOPCO-LTD
Xtx Topco Ltd
95%
13F/ownership overlay lists Xtx Topco Ltd; shares held 39,445; ownership 0.09%; value $7,979; as of 2025-12-31.
TOVX-OWNER-UBS-GROUP-AG
UBS Group AG
95%
13F/ownership overlay lists UBS Group AG; shares held 191,410; ownership 0.42%; value $38,722; as of 2025-12-31.
TOVX-OWNER-DRW-SECURITIES-LLC
DRW Securities, LLC
95%
13F/ownership overlay lists DRW Securities, LLC; shares held 41,745; ownership 0.09%; value $8,445; as of 2025-12-31.
TOVX-OWNER-IKARIAN-CAPITAL-LLC
Ikarian Capital, LLC
95%
13F/ownership overlay lists Ikarian Capital, LLC; shares held 112,076; ownership 0.24%; value $22,672; as of 2025-12-31.
TOVX-OWNER-STONEX-GROUP-INC
Stonex Group Inc.
95%
13F/ownership overlay lists Stonex Group Inc.; shares held 37,217; ownership 0.08%; value $7,528; as of 2025-12-31.
Theriva Biologics, Inc. Extended Supply Chain Network
